JanWillem Duitman Selected Research

CCAAT-Enhancer-Binding Protein-delta

1/2021	Non-Tumor CCAAT/Enhancer-Binding Protein Delta Potentiates Tumor Cell Extravasation and Pancreatic Cancer Metastasis Formation.
9/2020	CCAAT/Enhancer-Binding Protein Delta (C/EBPδ): A Previously Unrecognized Tumor Suppressor that Limits the Oncogenic Potential of Pancreatic Ductal Adenocarcinoma Cells.
1/2014	CCAAT-enhancer binding protein delta (C/EBPδ) attenuates tubular injury and tubulointerstitial fibrogenesis during chronic obstructive nephropathy.
12/2012	CCAAT-enhancer binding protein delta (C/EBPδ) protects against Klebsiella pneumoniae-induced pulmonary infection: potential role for macrophage migration.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

JanWillem Duitman Research Topics

Disease

6	Pulmonary Fibrosis (Fibrosing Alveolitis) 06/2022 - 10/2012
5	Neoplasms (Cancer) 01/2021 - 11/2014
5	Fibrosis (Cirrhosis) 01/2021 - 09/2014
5	Diabetic Nephropathies (Diabetic Nephropathy) 10/2019 - 01/2016
4	Pancreatic Neoplasms (Pancreatic Cancer) 01/2022 - 11/2014
4	Adenocarcinoma 01/2022 - 04/2020
3	Disease Progression 04/2020 - 11/2014
2	Neoplasm Metastasis (Metastasis) 01/2021 - 04/2020
2	COVID-19 01/2021 - 01/2021
2	Type 1 Diabetes Mellitus (Autoimmune Diabetes) 10/2019 - 01/2017
2	Infections 11/2016 - 12/2012
2	Bacterial Infections (Bacterial Infection) 05/2015 - 12/2012
2	Inflammation (Inflammations) 05/2015 - 01/2014
1	Respiratory Distress Syndrome (Acute Respiratory Distress Syndrome) 01/2021
1	Critical Illness (Critically Ill) 01/2021
1	Body Weight (Weight, Body) 10/2019
1	Type 2 Diabetes Mellitus (MODY) 10/2019
1	Pneumococcal Pneumonia 11/2018
1	Pneumonia (Pneumonitis) 11/2018
1	Hyperglycemia 04/2018
1	Albuminuria 04/2018
1	Idiopathic Pulmonary Fibrosis 01/2018
1	Lung Injury 01/2018
1	Sepsis (Septicemia) 05/2017
1	Respiratory Tract Diseases (Respiratory Tract Disease) 01/2017
1	Pathologic Processes 01/2017
1	Meningitis 11/2016
1	Atrophy 01/2016
1	Proteinuria 01/2016
1	Pneumococcal Meningitis (Streptococcus pneumoniae Meningitis) 05/2015
1	Acute-Phase Reaction 12/2012

Drug/Important Bio-Agent (IBA)

10	Peptide Hydrolases (Proteases)FDA Link 04/2020 - 10/2012
5	Bleomycin (Blenoxane)FDA LinkGeneric 06/2022 - 10/2012
5	Transcription Factors (Transcription Factor)IBA 01/2021 - 01/2014
4	CCAAT-Enhancer-Binding Protein-deltaIBA 01/2021 - 12/2012
4	Proteinase-Activated ReceptorsIBA 10/2019 - 11/2014
3	CytokinesIBA 01/2021 - 05/2017
3	CCAAT-Enhancer-Binding ProteinsIBA 09/2020 - 05/2015
3	Streptozocin (Streptozotocin)FDA Link 04/2018 - 01/2016
3	human airway trypsin-like proteaseIBA 01/2018 - 01/2017
2	DNA (Deoxyribonucleic Acid)IBA 06/2022 - 01/2021
2	vorapaxarIBA 10/2019 - 04/2018
2	PAR-2 ReceptorIBA 11/2018 - 01/2017
2	Cystatin CIBA 01/2018 - 01/2016
1	Interleukin-4 (Interleukin 4)IBA 06/2022
1	MethyltransferasesIBA 06/2022
1	Gemcitabine FDA Link 01/2022
1	DeoxycytidineIBA 01/2022
1	Fluorouracil (Carac)FDA LinkGeneric 01/2022
1	Paclitaxel (Taxol)FDA LinkGeneric 01/2022
1	Complement System Proteins (Complement)IBA 01/2021
1	Hydroxyproline (4 Hydroxyproline)IBA 01/2021
1	LigandsIBA 01/2021
1	Proteins (Proteins, Gene)FDA Link 01/2021
1	platelet activating factor receptorIBA 01/2021
1	ChemokinesIBA 01/2021
1	Intercellular Signaling Peptides and Proteins (Growth Factors)IBA 01/2021
1	DioxygenasesIBA 01/2021
1	AgarIBA 09/2020
1	Biomarkers (Surrogate Marker)IBA 04/2020
1	Metalloproteases (Metalloproteinases)IBA 04/2020
1	Blood Glucose (Blood Sugar)IBA 10/2019
1	Antineoplastic Agents (Antineoplastics)IBA 09/2019
1	Immune Checkpoint InhibitorsIBA 09/2019
1	nintedanibIBA 09/2019
1	Immune Checkpoint ProteinsIBA 09/2019
1	Tryptases (Tryptase)IBA 11/2018
1	Thromboplastin (Tissue Factor)IBA 11/2018
1	Factor VIIa (Activated Factor VII)IBA 11/2018
1	Fibronectins (Fibronectin)IBA 04/2018
1	HGF activatorIBA 01/2018
1	Matrix Metalloproteinases (MMPs)IBA 01/2018
1	Dinoprostone (PGE2)FDA Link 01/2018
1	CathepsinsIBA 01/2018
1	matriptaseIBA 01/2018
1	Plasminogen InactivatorsIBA 01/2018
1	Messenger RNA (mRNA)IBA 05/2017
1	Mitogen-Activated Protein KinasesIBA 05/2017
1	p38 Mitogen-Activated Protein KinasesIBA 05/2017
1	Serine Proteases (Serine Protease)IBA 01/2017
1	Glucose (Dextrose)FDA LinkGeneric 01/2016
1	Protein CIBA 01/2016

Therapy/Procedure

1	Drug Therapy (Chemotherapy) 01/2022
1	Intranasal Administration 01/2021
1	Artificial Respiration (Mechanical Ventilation) 01/2021
1	Therapeutics 01/2018